Efficacy and Safety of Intravitreal Aflibercept Treat and Extend for Polypoidal Choroidal Vasculopathy in the ATLANTIC Study: A Randomized Clinical Trial.
Silva R, Arias L, Nunes S, Farinha C, Coimbra R, Marques JP, Cachulo ML, Figueira J, Barreto P, Madeira MH, Pires I, Sousa JC, Distefano L, Rosa P, Carneiro Â, Vaz-Pereira S, Meireles A, Cabrera F, Bures A, Mendonça L, Fernandez-Vega-Sanz A, Barrão S, Koh A, Cheung CMG, Cunha-Vaz JG, Murta J; EVICR.net ATLANTIC Study Group.
Ophthalmologica. 2021 Jul 13. doi: 10.1159/000518235. Epub ahead of print
Genetic risk variants for Age-related Macular Degeneration in a Portuguese population – the Coimbra Eye Study.
Coimbra R, Farinha C, Barreto P, Madeira M, Silva R.
J Stat Health Decis. 2021;3(1):33-35.| https://doi.org/10.34624/jshd.v3i1.24799
2021
Projeto / Project nº: EXPL/EMD-EMD/1402/2021
Sistema de Incentivos / Funding System:
Sistema de Apoio à Investigação Científica e Tecnológica – Projetos de investigação de caráter exploratório (PeX)
Designação do Projeto:
RetFLUIMAPPING – Desenvolvimento e validação de um método para mapeamento de fluido extracelular na retina
Project Title:
RetFLUIMAPPING – Development and validation of OCT-based Abnormal Retinal FluidMapping
Objetivo/Aim:
O projeto Retinal FluidMAPPING tem como objetivo desenvolver um protótipo de software tendo em consideração a perspetiva da utilização na prática clínica, respondendo à necessidade de um biomarcador prognóstico da resposta ao tratamento do Edema Macular Diabético, facilitando um acompanhamento oftalmológico personalizado que permita melhor eficácia terapêutica e consequentemente reduzir encargos sociais e económicos do tratamento do Edema Macular Diabético.
Purpose:
The project Retinal FluidMAPPING has the goal of developing a software prototype tool that maps and quantifies abnormal accumulations of retinal fluid to be used as a Diabetic Macular Edema prognostic biomarker, facilitating a personalized ophthalmological healthcare and consequent reduction of societal and economic burden of Diabetic Macular Edema.
Custo Total / Total Cost: 49.966,25€
Financiamento / Funding: 49.966,25€
Localização / Location: Edif. Prof. Doutor José Cunha-Vaz, Azinhaga Sta. Comba, Celas, 3000-548 Coimbra, Portugal
Prazo de Execução / Timelines: 01-01-2022 – 30-06-2023
The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis
Alves C, Penedones A, Mendes D, Batel-Marques F.
J Clin Rheumatol . 2021 Apr 24. doi: 10.1097/RHU.0000000000001749
2021
https://journals.lww.com/jclinrheum/Abstract/9000/The_Risk_of_Infections_Associated_With_JAK.98358.aspx
Standardization of Optical Coherence Tomography Angiography Imaging Biomarkers in Diabetic Retinal Disease
Vujosevic S.; Cunha-Vaz J.; Figueira J.; Löwenstein A.; Midena E.; Parravano M.; Scanlon P.H.; Simó R.; Hernández C.; · Madeira M.H.; Marques I.P.; C.-V. Martinho A.; Santos A.R.; · Simó-Servat O.; Salongcay R.P.; Zur D.; Peto T.
Ophthalmic Res. 2021;64(6):871-887. doi: 10.1159/000518620
2021
Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading
Aires ID, Ribeiro-Rodrigues T, Boia R, Ferreira-Rodrigues M, Girão H, Ambrósio AF, Santiago AR
Biomolecules 2021 May 21;11(6):770. doi: 10.3390/biom11060770
2021
https://www.mdpi.com/2218-273X/11/6/770
Microglial exosomes in retinal neuroinflammation: focus in glaucoma
Aires ID and Santiago AR
Neural Regen Res. 2021 Sep;16(9):1801-1802. doi: 10.4103/1673-5374.306084
2021
https://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=9;spage=1801;epage=1802;aulast=Aires
Retina and Brain Display Early and Differential Molecular and Cellular Changes in the 3xTg-AD Mouse Model of Alzheimer’s Disease
Neves ACR, Carecho R, Correia SC, Carvalho C, Campos EJ, Baptista FI, Moreira PI, Ambrósio AF
Mol Neurobiol. 2021 Feb 19. doi: 10.1007/s12035-021-02316-x
2021
